Annual Drug Patent Expirations for AMTURNIDE
Amturnide is a drug marketed by Novartis and is included in one NDA. There are two patents protecting this drug.
This drug has one hundred and thirteen patent family members in thirty-one countries.
The generic ingredient in AMTURNIDE is aliskiren hemifumarate; amlodipine besylate; hydrochlorothiazide. Additional details are available on the aliskiren hemifumarate; amlodipine besylate; hydrochlorothiazide profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
